When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Net price of Catalyst Pharma's Firdapse to be $300K+ per year
Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals (CPRX+2.4%) says that the net price per year for LEMS med Firdapse (amifampridine) will be $300K - 318,750 per year, representing about a 15 - 20% discount off the $375K list price. The net price includes rebates to insurers and other discounts.
More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,